Cyclooxygenase 2 overexpression occurs in approximately 40% of invasive breast cancer, and is more common in tumours with large size, lymph node metastasis, a ductal type of histology, high histological grade, or negative hormone receptor status (Ristimaki et al, 2002). The gene discussed is NR4A1; the disease is neoplasm.